Real Estate
Why Pharma Companies are Flocking to Hyderabad for R&D
CBRE's 'Global Life Sciences Atlas' highlights why Hyderabad is becoming a top destination for pharmaceutical research and development. The city's strategic advantages are attracting global pharma giants, making it a hub for innovation and growth in the healthcare sector.
Real Estate
Why Pharma Companies are Flocking to Hyderabad for R&D
CBRE's 'Global Life Sciences Atlas' highlights why Hyderabad is becoming a top destination for pharmaceutical research and development. The city's strategic advantages are attracting global pharma giants, making it a hub for innovation and growth in the healthcare sector.
Real Estate
Hyderabad: A Global Hub for Life Sciences Manufacturing
Hyderabad has emerged as a leading global center for life sciences manufacturing, with a record-breaking 10 million square feet of dedicated space in 2024. CBRE, the world's leading real estate consulting firm, highlights the city's significant growth in its latest report.
Real Estate
Hyderabad: A Global Hub for Life Sciences Manufacturing
Hyderabad has emerged as a leading global center for life sciences manufacturing, with a record-breaking 10 million square feet of dedicated space in 2024. CBRE, the world's leading real estate consulting firm, highlights the city's significant growth in its latest report.
Real Estate Mumbai
CBRE India Launches Investment IQ: The First Real-Time Investment Risk Monitoring Tool in India
Mumbai, Maharashtra [India], April 23: CBRE South Asia Pvt. Ltd, a leading real estate consulting firm in India, has announced the launch of Investment IQ, a groundbreaking real-time investment risk monitoring tool. This innovative tool is designed to provide investors with comprehensive data and insights, enhancing their decision-making processes in the dynamic Indian real estate market.
Real Estate Pune
Real Estate Investment Set to Soar in 2025: 70% of Investors Plan to Increase Allocations
According to a recent survey by CBRE, 70% of real estate investors plan to increase their allocations in 2025, driven by optimistic market conditions and rising demand in key sectors.